title: Myelodysplastic subclones in chronic myeloid leukemia: implications for imatinib mesylate therapy.
authors.forename: Stuart L
authors.initials: SL
authors.lastname: Goldberg
authors.forename: Ravi A
authors.initials: RA
authors.lastname: Madan
authors.forename: Scott D
authors.initials: SD
authors.lastname: Rowley
authors.forename: Andrew L
authors.initials: AL
authors.lastname: Pecora
authors.forename: Jack W
authors.initials: JW
authors.lastname: Hsu
authors.forename: Ramana
authors.initials: R
authors.lastname: Tantravahi
mesh_terms: D001549:Benzamides; D019070:Cell Lineage; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D002999:Clone Cells / Q000473:pathology; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques; D009190:Myelodysplastic Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate